(lp0
S"Progenics Pharmaceuticals: Is It Time To Buy? Seeking Alpha - 16 hours ago Progenics Pharmaceuticals, Inc.  is an oncology company developing medicines and other products for targeting and treating cancer.Latest Updates :Progenics Pharmaceuticals, Inc.'s  stock price is Worth ... - Hot Stocks PointThe Progenics Pharmaceuticals, Inc.  Short Interest Update - Petro Global News 24"
p1
aS'Progenics Pharmaceuticals: What To Do Now After Azedra Results Seeking Alpha - Mar 31, 2017 I had a myriad of questions yesterday on Progenics Pharmaceuticals . The stock was down more than 10% at one point in trading Thursday before recovering a decent amount of those losses by market close.'
p2
aS"Progenics Pharmaceuticals Announces Positive Topline Results from ... GlobeNewswire  - Mar 30, 2017 NEW YORK, March 30, 2017  -- Progenics Pharmaceuticals, Inc. , an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that the Company's&nbsp;..."
p3
aS'Progenics Pharmaceuticals Inc.  Plunges 6.16% on March 30 Equities.com - Mar 30, 2017 Progenics Pharmaceuticals Inc.  had a rough trading day for Thursday March 30 as shares tumbled 6.16%, or a loss of $-0.63 per share, to close at $9.60.'
p4
aS"The Technicals For Progenics Pharmaceuticals, Inc.  Have Been Dissected ... NY Stock News - Mar 31, 2017 Progenics Pharmaceuticals, Inc.  has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment."
p5
aS'Do Analysts See Any Promise for Progenics Pharmaceuticals, Inc. ? Midway Monitor - 17 hours ago Research brokerage firms on Wall Street are offering a consensus Buy rating on shares of Progenics Pharmaceuticals, Inc. . Using the following ratings scale: 1.0 Strong Buy, 2.0 Buy, 3.0 Hold, 4.0 Sell and 5.0 Strong Sell, analysts have ...'
p6
aS'Progenics Pharmaceuticals Inc.  reported Market Capitalization of ... The Newburgh Press - Apr 13, 2017 Progenics Pharmaceuticals Inc.  reported sales  of 69.4 Million, whereas, 4 number of analysts estimated the mean sale of 5.2 million.The Way Wall Street Experts See Progenics Pharmaceuticals, Inc.  And ... - Post AnalystAverage Price Target Of 12.20 Issued For Progenics Pharmaceuticals Inc ... - Fiscal Standard'
p7
aS"Why Progenics Pharmaceuticals Inc's  ROE Of 11% Does Not Tell The Whole ... Simply Wall St - Mar 31, 2017 Progenics Pharmaceuticals Inc  generated a 11% ROE in the last year, compared to its industry's 27.48% ROE."
p8
aS'Option Market Alert: Progenics Pharmaceuticals Inc Implied Price Swing Hits An ... CML News - Mar 19, 2017 Risk Alert: Before we dive into any analysis we simply note that Progenics Pharmaceuticals Inc  risk is elevated.'
p9
aS'Traders Take Note: Progenics Pharmaceuticals Inc  Stock Drops ... CML News - Apr 12, 2017 Take Note: Progenics Pharmaceuticals Inc  has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics and&nbsp;...'
p10
a.